April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Thrombospondin-1 Expressed by Tgfbeta-Treated Antigen Presenting Cells Promotes Treg Induction by Inhibiting Th17 Development
Author Affiliations & Notes
  • S. Masli
    Ophthalmology/Harvard Med Sch, Schepens Eye Research Institute, Boston, Massachusetts
  • B. Turpie
    Ophthalmology/Harvard Med Sch, Schepens Eye Research Institute, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  S. Masli, None; B. Turpie, None.
  • Footnotes
    Support  EY015472
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 4833. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Masli, B. Turpie; Thrombospondin-1 Expressed by Tgfbeta-Treated Antigen Presenting Cells Promotes Treg Induction by Inhibiting Th17 Development. Invest. Ophthalmol. Vis. Sci. 2010;51(13):4833.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Expression of thrombospondin-1 (TSP-1) is critical to the ocular immune privilege as it contributes significantly to the regulatory immune response induced by TGF-β-exposed ocular antigen presenting cells (APCs). Such TGFβ-exposed APCs produce increased amounts of active TGFβ in a TSP-1-dependent manner and induce TGFβ-secreting regulatory T cells (Treg). In the context of a key role ascribed to TGFβ in the development of functionally disparate subsets, Treg and Th17, we now examine relevance of APC-derived TSP-1 in development of the former subset over the latter.

Methods: : Thioglycollate-elicited peritoneal exudates cells from C57BL/6 (WT) or TSP1null mice were used as APCs. These cells, pulsed with ovalbumin, were cultured overnight in the presence or absence of TGFβ (5 ng/ml) before co-culturing with CD4+CD25- T cells from OT-II mice. Expression of FoxP3 was evaluated in CD4+CD25+ T cells by flow cytometry. Activated cells were restimulated in a fresh culture with plate bound anti-CD3 and IL-17, IL-6 and TGFβ in culture supernatants were measured by ELISA. Expression of IL-23 by LPS-stimulated WT APCs in the presence of TSP1 or peptide derived from the C-terminal domain of TSP-1 or control peptide was assessed by real-time PCR and ELISA.

Results: : The number of CD4+CD25+FoxP3+ T cells increased among T cells co-cultured with TGFβ-treated WT APCs as compared to untreated APCs, which corresponded with their significantly decreased ability to secrete IL-6 and IL-17 as compared to the controls. Exposure of TSP1null APCs to TGFβ failed to do so. Untreated TSP1null APCs induced significantly increased level of IL-17 secretion by activated T cells as compared to the WT control APCs. Exposure of WT APCs to both TGFβ and TSP1 derived peptide led to inhibition of Th17-promoting cytokine IL-23, while CD4+CD25- T cells treated with TSP1 derived peptide increased expression of TGFβ and Foxp3 as compared to those exposed to control peptide.

Conclusions: : Regulatory response induced by TGFβ-exposed APCs includes immunosuppressive CD4+CD25+FoxP3+ Tregs, development of which is facilitated by APC-derived TSP1 over that of inflammatory Th17 effectors in a TGFβ-independent manner.

Keywords: antigen presentation/processing • immunomodulation/immunoregulation • immune tolerance/privilege 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×